全文获取类型
收费全文 | 2199篇 |
免费 | 158篇 |
国内免费 | 115篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 77篇 |
妇产科学 | 29篇 |
基础医学 | 233篇 |
口腔科学 | 34篇 |
临床医学 | 241篇 |
内科学 | 472篇 |
皮肤病学 | 62篇 |
神经病学 | 175篇 |
特种医学 | 439篇 |
外国民族医学 | 1篇 |
外科学 | 206篇 |
综合类 | 70篇 |
预防医学 | 159篇 |
眼科学 | 17篇 |
药学 | 156篇 |
中国医学 | 1篇 |
肿瘤学 | 97篇 |
出版年
2021年 | 15篇 |
2020年 | 14篇 |
2019年 | 28篇 |
2018年 | 25篇 |
2017年 | 13篇 |
2016年 | 32篇 |
2015年 | 38篇 |
2014年 | 35篇 |
2013年 | 60篇 |
2012年 | 61篇 |
2011年 | 76篇 |
2010年 | 71篇 |
2009年 | 67篇 |
2008年 | 53篇 |
2007年 | 127篇 |
2006年 | 73篇 |
2005年 | 97篇 |
2004年 | 49篇 |
2003年 | 51篇 |
2002年 | 46篇 |
2001年 | 39篇 |
2000年 | 42篇 |
1999年 | 45篇 |
1998年 | 95篇 |
1997年 | 103篇 |
1996年 | 111篇 |
1995年 | 70篇 |
1994年 | 70篇 |
1993年 | 71篇 |
1992年 | 28篇 |
1991年 | 42篇 |
1990年 | 43篇 |
1989年 | 67篇 |
1988年 | 52篇 |
1987年 | 63篇 |
1986年 | 41篇 |
1985年 | 54篇 |
1984年 | 28篇 |
1983年 | 23篇 |
1982年 | 32篇 |
1981年 | 24篇 |
1980年 | 34篇 |
1979年 | 24篇 |
1978年 | 23篇 |
1977年 | 32篇 |
1976年 | 30篇 |
1975年 | 27篇 |
1974年 | 11篇 |
1973年 | 12篇 |
1966年 | 11篇 |
排序方式: 共有2472条查询结果,搜索用时 15 毫秒
51.
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen 总被引:1,自引:0,他引:1
We have studied the use of a new preparative regimen for the treatment of patients in remission of acute myeloid leukemia (AML) with autologous bone marrow transplantation. Chemotherapy consisted of busulfan 1 mg/kg every 6 hours for 4 days (total dose, 16 mg/kg) on days -7 through -4 followed by an intravenous infusion over 6 to 10 hours of etoposide 60 mg/kg on day -3. Autologous bone marrow, treated in vitro with 100 micrograms/mL of 4-hydroperoxycyclophosphamide, was infused on day 0. We have treated 58 patients up to the age of 60 years, 32 in first remission, 21 in second or third remission, and 5 with primary refractory AML unresponsive to high-dose Ara-C, but achieving remission with aggressive salvage regimens. Of the first remission patients, there has been 1 treatment related death and 5 relapses. With median follow-up of 22 months, the actuarial relapse rate is 22% +/- 9% and disease-free survival is 76% +/- 9% at 3 years. Patients with favorable French-American-British (FAB) subtypes (M3 or M4 EO) did especially well, with no relapses seen in 15 patients observed for a median of 30 months. Actuarial relapse rate at 3 years was 48% for first remission patients with less favorable FAB subtypes. Of patients in second or third remission, there were 5 treatment related deaths and 4 relapses. With median follow-up of 22 months, the actuarial relapse rate is 25% +/- 11% and disease-free survival is 56% +/- 11% at 3 years. Four of five primary refractory patients died during treatment and 1 remains in remission with short follow-up. These preliminary data are very encouraging and, if confirmed, support the use of autologous purged bone marrow transplantation using aggressive preparative regimens as one approach to improve the outcome of adults with AML. 相似文献
52.
A new quantitative immunoperoxidase method is presented for determining absolute amounts of peroxidase and, consequently, surface antigen densities of individual cells in B lymphocytes from normal individuals, from subjects with CLL and prolymphocytic leukemia, and during ontogeny of B lympocytes in the mouse. The following results were observed: (1) The density of B antigenic sites were lower on CLL than on normal B lymphocytes. (2) The B antigens density of leukemic lymphocytes varied less from cell to cell, forming a homogeneous peak on histograms. (3) In a very rare case of CLL, the antigen density was measured at the time of initial diagnosis (22,500 sites or 647 U) and during the development of a blastic crisis (135,000 sites or 2576 U). The cell by cell distribution changed from a homogeneous peak with a low number of antigenic sites per cell to a heterogeneous peak with a high number of antigenic sites per cell. (4) In prolymphocytic leukemia, the density of B antigenic sites was greater than on normal B lymphocytes and much more heterogeneous than on CLL lymphocytes. (5) During ontogeny of B lymphocytes in the mouse, maturation is associated with the appearance of a population of cells of intermediate to high Smig density. The finding of a decrease in, and altered distribution of, surface markers in CLL is compared with these ontologic findings in the mouse, and the concept that a monoclonal B lymphocyte in CLL may be arrested at a particular stage in its differentiation is discussed. 相似文献
53.
54.
Marc-Antoine de La Vega Grazia Caleo Jonathan Audet Xiangguo Qiu Robert A. Kozak James I. Brooks Steven Kern Anja Wolz Armand Sprecher Jane Greig Kamalini Lokuge David K. Kargbo Brima Kargbo Antonino Di Caro Allen Grolla Darwyn Kobasa James E. Strong Giuseppe Ippolito Michel Van Herp Gary P. Kobinger 《The Journal of clinical investigation》2015,125(12):4421-4428
BACKGROUND. Ebola virus (EBOV) causes periodic outbreaks of life-threatening EBOV disease in Africa. Historically, these outbreaks have been relatively small and geographically contained; however, the magnitude of the EBOV outbreak that began in 2014 in West Africa has been unprecedented. The aim of this study was to describe the viral kinetics of EBOV during this outbreak and identify factors that contribute to outbreak progression.METHODS. From July to December 2014, one laboratory in Sierra Leone processed over 2,700 patient samples for EBOV detection by quantitative PCR (qPCR). Viremia was measured following patient admission. Age, sex, and approximate time of symptom onset were also recorded for each patient. The data was analyzed using various mathematical models to find trends of potential interest.RESULTS. The analysis revealed a significant difference (P = 2.7 × 10–77) between the initial viremia of survivors (4.02 log10 genome equivalents [GEQ]/ml) and nonsurvivors (6.18 log10 GEQ/ml). At the population level, patient viral loads were higher on average in July than in November, even when accounting for outcome and time since onset of symptoms. This decrease in viral loads temporally correlated with an increase in circulating EBOV-specific IgG antibodies among individuals who were suspected of being infected but shown to be negative for the virus by PCR.CONCLUSIONS. Our results indicate that initial viremia is associated with outcome of the individual and outbreak duration; therefore, care must be taken in planning clinical trials and interventions. Additional research in virus adaptation and the impacts of host factors on EBOV transmission and pathogenesis is needed. 相似文献
55.
56.
S Wurtzer V Marechal JM Mouchel Y Maday R Teyssou E Richard JL Almayrac L Moulin 《Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin》2020,25(50)
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease (COVID-19). People infected with SARS-CoV-2 may exhibit no or mild non-specific symptoms; thus, they may contribute to silent circulation of the virus among humans. Since SARS-CoV-2 RNA can be detected in stool samples, monitoring SARS-CoV-2 RNA in waste water (WW) has been proposed as a complementary tool to investigate virus circulation in human populations.AimTo test if the quantification of SARS-CoV-2 genomes in WW correlates with the number of symptomatic or non-symptomatic carriers.MethodWe performed a time-course quantitative analysis of SARS-CoV-2 by RT-qPCR in raw WW samples collected from several major WW treatment plants in Greater Paris. The study period was 5 March to 23 April 2020, including the lockdown period in France (from 17 March).ResultsWe showed that the increase of genome units in raw WW accurately followed the increase of human COVID-19 cases observed at the regional level. Of note, the viral genome could be detected before the epidemic grew massively (around 8 March). Equally importantly, a marked decrease in the quantities of genome units was observed concomitantly with the reduction in the number of new COVID-19 cases, 29 days following the lockdown.ConclusionThis work suggests that a quantitative monitoring of SARS-CoV-2 genomes in WW could generate important additional information for improved monitoring of SARS-CoV-2 circulation at local or regional levels and emphasises the role of WW-based epidemiology. 相似文献
57.
58.
59.
60.